Calyxt joins Bioindustrial Manufacturing and Design Ecosystem (BioMADE), a Department of Defense initiative, to advance sustainable plant-based biomanufacturing

Calyxt, Inc. (NASDAQ: CLXT), a plant-based synthetic biology company, announced that it has become a member of Bioindustrial Manufacturing and Design Ecosystem (BioMADE), a Department of Defense initiated Manufacturing Innovation Institute dedicated to advancing bioindustrial manufacturing across the nation.

BioMADE membership includes a diverse network of large corporations, innovative start-ups, universities and not-for-profit research organizations to elevate and secure U.S. global leadership in advanced bioindustrial manufacturing. Calyxt intends to work with BioMADE and its nationwide roster of collaborating organizations toward BioMADE's goal of securing America's future through bioindustrial manufacturing innovation, education and collaboration.

"We are looking forward to collaborating with BioMADE and its member organizations to advance the development of our plant-based technology into sustainable bioproducts," said Calyxt President and CEO Michael A. Carr. "The bioindustrial manufacturing and broader bioeconomy ecosystem is poised for significant growth, and by joining BioMADE we are positioning Calyxt to be part of that growth."

"BioMADE is excited to welcome Calyxt into its select membership network," said BioMADE Chief Technology Officer Melanie Tomczak. "Calyxt's strength and knowledge in engineering sustainable plant-based solutions will bring important experience and expertise to the BioMADE community, as we collectively build the American bioindustrial manufacturing ecosystem. We are pleased, in pursuing this mission, to have Calyxt among our collaborators."

In September, the White House announced funding of more than $2 billion to launch the National Biotechnology and Biomanufacturing Initiative to lower prices, create good jobs, strengthen supply chains, improve health outcomes, and reduce carbon emissions.

BioMADE also provides its members with opportunities for access to federal funding, industry collaboration and broader engagement in supporting the development of biomanufacturing technologies to strengthen US bioindustrial competitiveness.